Press Releases
 
Erythropoietin Stimulating Agent Market Growth Focusing on Trends & Innovations during the Period un

, 11 July 2019 -- Global Erythropoietin Stimulating Agent Market is driven by increasing number of patients suffering from anemia, anemia induced due to cancer and end stage renal disease (ESRD).

Blood carries oxygen which is required for a healthy body functioning. When the concentration of oxygen is reduced in the blood then an oxygen-sensing protein present in the kidney identifies the deficiency of oxygen gradient in the blood and then induces the EPO production,which then turns upon the erythroid cell line in the bone marrow to stimulate hematopoiesis and thus it response to the change in blood oxygen gradient. Endogenous erythropoietin (EPO) is a glycoprotein hematopoietic hormone, which is synthesized, in the renal tubules. EPO helps in controlling and regulating the mechanism of erythropoiesisin the bone marrow.

Report Overview @ https://www.transparencymarketresearch.com/erythropoietin-stimulating-agent-market.html

Due to anemia and renal problem, the production of erythropoietin (EPO) istroubled, resulting into fatigue, weakness, shortness of breath, pale skin and insomnia.For treating anemia,chemotherapy induced anemia, renal disorders and others erythropoietin stimulating drugs (EPO) are used.For development of synthetic form of erythropoietin drugs such as epoetin alfa, epoetin beta, darbepoetin alfa, epoetin delta, epoetin omega and others with the help of improved recombinant DNA technology.Recombinant erythropoietin is an artificialformof natural erythropoietin. These are made by cloning the gene for erythropoietin. Among synthetic EPO’sepoetin alfa, epoetin beta, epoetin omega, epoetin delta and darbepoetin-alpha are used extensively. Epoetin delta is another recombinant EPO that is been used for treating patients with chronic kidney disease (CKD).

Request Brochure @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=8794

GlobalErythropoietin stimulating agent market are driven by increasing number of patients suffering from anemia, anemia induced due to cancer, end stage renal disease (ESRD) and HIV treatment. In June 1989,Epoetin alfa was the first drug for EPO, manufactured by Amgen Inc. U.S FDA approved itunder the trade name “Epogen”.The global market for erythropoietin drugs are expected to grow in near future as increased cases of cancer and renal problem haveregistered. With the expiration of Amgen’s patent for Epogen, it has helped the production of other biosimilars EPO drugs. Hence, availability of many biosimilar drugs has renderedlow-cost option to the patients, therefore particularly, in the developing regions the adoption of EPO drugs have increased.

Based on product type erythropoietin stimulating agent can divided as Epoetin-alfa, Epoetin-beta, epoetin omega, epoetin delta and darbepoetin-alpha. Application of erythropoietin stimulating agents are classified as anemia, cancer chemotherapy, kidney disorders (ESRD and dialysis), antiretroviral treatment (ART) and others (neural disease and wound healing),

Request for TOC @ https://www.transparencymarketresearch.com/sample/sample.php?flag=T&rep_id=8794

Some of the major players in erythropoietin stimulating agent market are Amgen Inc., Biocon, Celltrion, Inc., Hospira Inc., Intas Pharmaceuticals, Johnson & Johnson, Ranbaxy Laboratories Ltd., Roche, LG Life Sciences Ltd. and Teva Pharmaceutical Industries Ltd.

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR syndicated research report covers a different sector – such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.

Contact Us

Transparency Market Research

90 State Street, Suite 700

Albany, NY 12207

Tel: +1-518-618-1030

USA – Canada Toll Free: 866-552-3453

Email:

Website: https://www.transparencymarketresearch.com

# # #


Submitted by hawer on Thursday, 11 July 2019 at 7:01 PM
Category: Health Care & Medical
 
Related News

Marfan Syndrome Treatment Market to Witness a Pronounce Growth by 2026
Wednesday, 24 Jul 2019

Gene Synthesis Market to Witness a Pronounce Growth by 2026
Wednesday, 24 Jul 2019

Cryotherapy Market Size, Share & Trend | Industry Analysis Report, 2026
Wednesday, 24 Jul 2019

Limb Salvage Surgery Market Overview and Regional Outlook Study 2018 – 2026
Wednesday, 24 Jul 2019

GnRH Agonists & Antagonists Market Size, Share & Trend | Industry Analysis Report, 2026
Wednesday, 24 Jul 2019

Related Events

Neuropsychiatric Drug Development Summit Boston
Tuesday, 23 Jul 2019

Cardiovascular and Respiratory Disease Summit (CARPS)
Wednesday, 24 Jul 2019

Orthopaedics for the Primary Care Practitioner and Rehabilitation Therapist
Friday, 26 Jul 2019

Oncology Update 2019 CME Conference - Los Angeles
Saturday, 27 Jul 2019

The National Conference on Wilderness Medicine Big Sky Resort, Montana
Saturday, 27 Jul 2019

Latest News

Marfan Syndrome Treatment Market to Witness a Pronounce Growth by 2026
Wednesday, 24 Jul 2019

Gene Synthesis Market to Witness a Pronounce Growth by 2026
Wednesday, 24 Jul 2019

Cryotherapy Market Size, Share & Trend | Industry Analysis Report, 2026
Wednesday, 24 Jul 2019

Limb Salvage Surgery Market Overview and Regional Outlook Study 2018 – 2026
Wednesday, 24 Jul 2019

GnRH Agonists & Antagonists Market Size, Share & Trend | Industry Analysis Report, 2026
Wednesday, 24 Jul 2019

 
Want to get your press releases, event listings, and job ads on Scoopasia? Register now for a FREE account or login if you already have one!
Scoopasia v1.0b. Copyright © 2019
Today is Wednesday, 24 July 2019

About Scoopasia | FAQ | Privacy Policy | Contact Us

Press Releases
Event Listings
Job Listings
Arts & Entertainment
Architecture & Construction
Automotive & Travel
Business
Consumer Technology
Economy
Education
Enterprise Technology
Food & Fashion
Government & Policy
Health Care & Medical
Legal/Law
News & Media
Religion
Science & Research
Sports & Fitness
Login / Register
Get Scoopasia through RSS Feeds & Email Notifications!


Journalist's Toolbox
Hello journalist, welcome to Scoopasia--a powerful online resource for media information in Asia. Scoopasia has press releases and media events for every beat and industry. All content on Scoopasia is 100% FREE. You don't even need to login!

  • Scoop Line
    (Instant Information Request)
    The easiest way to ask questions and request information from the PR community.


  • Advanced Search
    Drill down, dig deep, for media information the way you want it.

  • Journalist's Resources
    Resources and tools you can't do without.

  • PR Tools
    Scoopasia Blog Search
    Search the largest handpicked collection of Asia's most prominent and influential blogs.


    Resources
  • PR Bookmarks
  • Web 2.0 Bookmarks
  • Media Bookmarks

    More Coming Soon...

  • Upcoming Events
  • Neuropsychiatric Drug Development Summit Boston
  • Chief Data and Analytics Officer Singapore
  • St. Louis Business Cannabis Expo
  • Cardiovascular and Respiratory Disease Summit (CARPS)
  • 61st London International Youth Science Forum

  • Latest Jobs
    Sorry, there are currently no entries posted here.